1. Home
  2. MRT vs IPHA Comparison

MRT vs IPHA Comparison

Compare MRT & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marti Technologies Inc.

MRT

Marti Technologies Inc.

HOLD

Current Price

$2.07

Market Cap

176.2M

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.87

Market Cap

165.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRT
IPHA
Founded
2018
1999
Country
Turkey
France
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.2M
165.3M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
MRT
IPHA
Price
$2.07
$1.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$3.58
$5.75
AVG Volume (30 Days)
51.8K
52.7K
Earning Date
08-08-2018
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$72.36
$180.36
Revenue Next Year
$95.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.12
$1.18
52 Week High
$2.75
$2.71

Technical Indicators

Market Signals
Indicator
MRT
IPHA
Relative Strength Index (RSI) 50.62 41.28
Support Level $1.99 $1.67
Resistance Level $2.24 $1.95
Average True Range (ATR) 0.15 0.08
MACD -0.02 -0.05
Stochastic Oscillator 34.15 0.00

Price Performance

Historical Comparison
MRT
IPHA

About MRT Marti Technologies Inc.

Marti Technologies Inc is Turkiye's urban mobility platform, helping to solve the country's transportation needs through tech-enabled services powered by a single mobility super app. The Group aims to offer tech-enabled urban transportation services to consumers across Turkiye through three service offerings: ride-hailing, delivery, and two-wheeled electric vehicle services. The Group's ride-hailing service matches consumers with car, motorcycle, and taxi drivers. The Group's delivery service provides same-hour package delivery by leveraging the Group's existing network of car and motorcycle drivers and consumer base.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: